San Diego is ranked the among the top genomics markets in the nation, with innovative companies paving the way for the future of medicine. Join us for the second in our San Diego: Life. Changing. virtual panel series, San Diego Science & the Global Pandemic: Genomics. With world leaders in next-generation sequencing right in our backyard, we have access to experts who will share the ways in which modern genomics can address COVID-19.

Just like last time, whether you have a PhD or you are a freshman-year-biology-class drop out, our expert panelists will break down the science for the non-scientists (like us) and tell you what you need to know about the future of precision medicine and COVID-19.

Once you complete the event registration, you will receive an email with the link to the webinar. At the very bottom of that email, there are options for adding the webinar link to your calendar.

Meet the panelists:

Gary P. Schroth, Ph.D. - Vice President and Distinguished Scientist, Illumina

Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he leads the Emerging Applications Group in Product Development. Gary obtained his Ph.D. in biochemistry from the University of California at Davis and has been working in the field of next-generation sequencing (NGS) for over 15 years as part of Illumina (and Solexa).

In his research Gary uses NGS to study genomics, gene structure, expression and regulation and applies this to projects in the fields of cancer, immunology, microbiology and infectious disease. Over the course of his career Dr. Schroth has been an author on more than 95 peer reviewed research papers and holds 19 U.S. patents.

Dr. James Lu, M.D., Ph.D. - Co-founder & Chief Science Officer, Helix

James is a co-founder and Chief Science Officer at Helix where he has responsibility for the scientific teams which includes bioinformatics, laboratory operations, regulatory, quality, translational research and policy teams.

Prior to Helix, James was a faculty member at Duke University where he focused on translational genomics and machine learning methodologies for electronic medical records. James has also explored a broad range of research topics in population genetics, Mendelian genomics, and computational psychiatry and has published dozens of papers in journals such as Nature, the New England Journal of Medicine and the Journal of Machine Learning Research. James holds an M.D. and Ph.D. from Baylor College of Medicine, where he was a member of the Alpha Omega Alpha Honor Society. He also received a B.S. and M.S. in Chemical Engineering from Stanford University.

Registrations are closed

San Diego Science & the Global Pandemic: Genomics